United States· US:72319-029_2ee941f2-7d8c-dd6e-e063-6394a90a0db9
METHSCOPOLAMINE BROMIDE
A medicinal product containing methscopolamine bromide, registered in United States by i3 Pharmaceuticals, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHSCOPOLAMINE BROMIDE
- Manufacturer
- i3 Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc117231902904100 TABLET in 1 BOTTLE (72319-029-04)
- ndc1172319029061000 TABLET in 1 BOTTLE (72319-029-06)
- ndc1172319-029-04
- ndc1172319-029-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6b41ff8-32a3-48f6-93bb-e77be5a2bf43 GET /v1/drugs/b6b41ff8-32a3-48f6-93bb-e77be5a2bf43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2.5",
"substance": "METHSCOPOLAMINE BROMIDE",
"productndc": "72319-029",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA216786",
"marketing_category": "ANDA"
}See everything about methscopolamine bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.